POTEJ

gene
On this page

Also known as POTE2beta

Summary

POTEJ (POTE ankyrin domain family member J, HGNC:37094) is a protein-coding gene on chromosome 2q21.1, encoding POTE ankyrin domain family member J (P0CG39).

Predicted to enable protein kinase binding activity. Predicted to be a structural constituent of postsynaptic actin cytoskeleton. Predicted to be involved in axonogenesis and cell motility. Located in extracellular exosome.

Source: NCBI Gene 653781 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 12 total
  • MANE Select transcript: NM_001277083

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:37094
Approved symbolPOTEJ
NamePOTE ankyrin domain family member J
Location2q21.1
Locus typegene with protein product
StatusApproved
AliasesPOTE2beta
Ensembl geneENSG00000222038
Ensembl biotypeprotein_coding
Entrez653781

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000409602

RefSeq mRNA: 1 — MANE Select: NM_001277083 NM_001277083

CCDS: CCDS59432

Canonical transcript exons

ENST00000409602 — 15 exons

ExonStartEnd
ENSE00001723108130611440130611942
ENSE00002434805130617065130617238
ENSE00002442943130616790130616904
ENSE00002453749130629949130630019
ENSE00002457441130645737130645781
ENSE00002461380130654921130655041
ENSE00002468159130631409130631453
ENSE00002470102130621466130621603
ENSE00002472997130620045130620151
ENSE00002496629130638619130638689
ENSE00002499512130624064130624134
ENSE00002501018130632490130632656
ENSE00002508231130646129130646310
ENSE00002509853130643983130644053
ENSE00002513344130656549130658037

Expression profiles

Bgee: expression breadth broad, 18 present calls, max score 81.19.

Top tissues by expression

119 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.19gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099149.57silver quality
cortical plateUBERON:000534345.27gold quality
ganglionic eminenceUBERON:000402344.07gold quality
prostate glandUBERON:000236738.53gold quality
bone marrow cellCL:000209238.21gold quality
colonic epitheliumUBERON:000039737.20gold quality
right atrium auricular regionUBERON:000663136.69gold quality
hindlimb stylopod muscleUBERON:000425236.10silver quality
sural nerveUBERON:001548835.27gold quality
right uterine tubeUBERON:000130234.93gold quality
testisUBERON:000047334.52gold quality
olfactory segment of nasal mucosaUBERON:000538633.96silver quality
bone marrowUBERON:000237133.83gold quality
tonsilUBERON:000237233.80gold quality
fundus of stomachUBERON:000116032.91gold quality
duodenumUBERON:000211432.48gold quality
endometriumUBERON:000129532.09gold quality
stomachUBERON:000094531.74silver quality
urinary bladderUBERON:000125531.71gold quality
left testisUBERON:000453331.59silver quality
bloodUBERON:000017831.58gold quality
mucosa of stomachUBERON:000119931.56gold quality
lymph nodeUBERON:000002930.93gold quality
right testisUBERON:000453430.89gold quality
prefrontal cortexUBERON:000045130.70gold quality
body of stomachUBERON:000116130.54gold quality
stromal cell of endometriumCL:000225529.87gold quality
liverUBERON:000210729.79gold quality
superior frontal gyrusUBERON:000266129.37gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.90

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

19 targeting POTEJ, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3646100.0073.565283
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-366299.9973.825684
HSA-MIR-570-3P99.9672.414910
HSA-MIR-6772-5P99.9467.01577
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-1211999.8768.351653
HSA-MIR-4762-3P99.4369.722363
HSA-MIR-425199.4069.193363
HSA-MIR-125399.1267.081688
HSA-MIR-6770-5P98.9766.761853
HSA-MIR-412-3P98.8666.89712
HSA-MIR-6754-3P98.8466.60889
HSA-MIR-430398.0168.132304
HSA-MIR-192-3P97.5267.661001
HSA-MIR-937-5P97.4368.39667
HSA-MIR-6872-3P97.0866.99750
HSA-MIR-4664-3P88.5763.7980

Cross-species orthologs

0 orthologs

Paralogs (16): BCL3 (ENSG00000069399), NFKBIE (ENSG00000146232), POTED (ENSG00000166351), POTEC (ENSG00000183206), POTEG (ENSG00000187537), POTEE (ENSG00000188219), POTEA (ENSG00000188877), POTEF (ENSG00000196604), POTEI (ENSG00000196834), POTEH (ENSG00000198062), POTEM (ENSG00000222036), POTEB2 (ENSG00000230031), POTEB (ENSG00000233917), (ENSG00000276760), (ENSG00000277630), POTEB3 (ENSG00000278522)

Protein

Protein identifiers

POTE ankyrin domain family member JP0CG39 (reviewed: P0CG39)

All UniProt accessions (1): P0CG39

UniProt curated annotations — full annotation on UniProt →

Similarity. In the N-terminal section; belongs to the POTE family. In the C-terminal section; belongs to the actin family.

RefSeq proteins (1): NP_001264012* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002110Ankyrin_rptRepeat
IPR004000ActinFamily
IPR004001Actin_CSConserved_site
IPR020902Actin/actin-like_CSConserved_site
IPR036770Ankyrin_rpt-contain_sfHomologous_superfamily
IPR039497CC144C-like_CC_domDomain
IPR043129ATPase_NBDHomologous_superfamily

Pfam: PF00022, PF12796, PF14915

UniProt features (15 total): repeat 5, compositionally biased region 5, region of interest 3, chain 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0CG39-F172.200.46

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 42 (showing top): GOBP_NEUROGENESIS, GOBP_CELL_JUNCTION_ORGANIZATION, GOCC_NEURON_PROJECTION, GOBP_CELL_PROJECTION_ORGANIZATION, GOCC_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX, GOCC_TRANSFERASE_COMPLEX, GOCC_SYNAPSE, GOCC_AXON, GOMF_KINASE_BINDING, GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, GOBP_SYNAPSE_ORGANIZATION, GOBP_AXON_DEVELOPMENT, GOBP_POSTSYNAPSE_ORGANIZATION, GOBP_POSTSYNAPTIC_CYTOSKELETON_ORGANIZATION

GO Biological Process (3): axonogenesis (GO:0007409), cell motility (GO:0048870), postsynaptic actin cytoskeleton organization (GO:0098974)

GO Molecular Function (3): protein kinase binding (GO:0019901), structural constituent of postsynaptic actin cytoskeleton (GO:0098973), protein binding (GO:0005515)

GO Cellular Component (9): obsolete extracellular space (GO:0005615), cytoplasm (GO:0005737), actin filament (GO:0005884), actin cytoskeleton (GO:0015629), membrane (GO:0016020), axon (GO:0030424), NuA4 histone acetyltransferase complex (GO:0035267), synapse (GO:0045202), extracellular exosome (GO:0070062)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
cell morphogenesis involved in neuron differentiation1
neuron projection morphogenesis1
axon development1
cellular process1
actin cytoskeleton organization1
postsynaptic cytoskeleton organization1
kinase binding1
structural constituent of cytoskeleton1
postsynaptic actin cytoskeleton1
postsynaptic actin cytoskeleton organization1
structural constituent of postsynapse1
binding1
intracellular anatomical structure1
actin cytoskeleton1
polymeric cytoskeletal fiber1
cytoskeleton1
neuron projection1
H4/H2A histone acetyltransferase complex1
cell junction1
extracellular vesicle1

Protein interactions and networks

STRING

578 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
POTEJTRIM49CP0CI26470
POTEJNMT1P30419456
POTEJAGAP4Q96P64400
POTEJCCDC183Q5T5S1394
POTEJPPP1R37O75864372
POTEJZNG1CQ5JTY5371
POTEJA0A087WTP8A0A087WTP8353
POTEJTRIM49P0CI25348
POTEJZNF418Q8TF45348
POTEJAMER3Q8N944322
POTEJGPR148Q8TDV2307
POTEJABRACLQ9P1F3297
POTEJARGLU1Q9NWB6290
POTEJCDH24Q86UP0271
POTEJVSIG2Q96IQ7270

IntAct

23 interactions, top by confidence:

ABTypeScore
CFTRESYT2psi-mi:“MI:0914”(association)0.710
BCL7AARID1Apsi-mi:“MI:0914”(association)0.640
INSRPIK3R2psi-mi:“MI:2364”(proximity)0.570
CFTRPLEKHG3psi-mi:“MI:0914”(association)0.480
CFTRCNOT1psi-mi:“MI:0914”(association)0.480
CATNUDT19psi-mi:“MI:0914”(association)0.420
BCL7ADPF1psi-mi:“MI:0914”(association)0.350
RIN3psi-mi:“MI:0914”(association)0.350
CTBP1TAF15psi-mi:“MI:0914”(association)0.350
CFTRPOTEFpsi-mi:“MI:0914”(association)0.350
HCN1POTEFpsi-mi:“MI:0914”(association)0.350
CAP2POTEFpsi-mi:“MI:0914”(association)0.350
PFN3POTEJpsi-mi:“MI:0914”(association)0.350
VP24POTEFpsi-mi:“MI:0914”(association)0.350
NDNHDLBPpsi-mi:“MI:2364”(proximity)0.270

BioGRID (77): POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS)

ESM2 similar proteins: A0A072TK64, A0A072ULZ1, A0A6P8HC43, A2PYL6, A2PYL7, A2PYL8, A2XE45, A2XEA0, A2Y6J9, A5A3E0, B5DUH6, E9Q0N2, F4HWL4, F4JCB2, O04309, O08528, O24521, O95744, P0CG38, P0CG39, P25071, P27881, P28316, P29127, P35753, P37842, P52789, Q1W674, Q29428, Q6S8J3, Q70SU7, Q70SU8, Q75II4, Q84JE8, Q8L727, Q8LRK8, Q8RXK2, Q8VC49, Q90WJ7, Q93Y92

Diamond homologs: A0A0A6YYL3, A0JP26, A0PJZ0, A2A2Z9, A2RUR9, A5A3E0, A6NC57, A6NI47, A7E2S9, B2RU33, H3BUK9, P0CG38, P0CG39, Q3MJ40, Q4R3S3, Q4UJ75, Q5CZ79, Q5JPF3, Q5SQ80, Q5TYW2, Q5VUR7, Q6NSI1, Q6S545, Q6S5H5, Q6S8J3, Q6S8J7, Q811D2, Q86YR6, Q8IYA2, Q92527, Q9BXX2, Q9BXX3, Q9D504, Q9H560, Q9UPS8, Q8IVF6, A6QL64, Q8N2N9, Q8NF67, Q96IX9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

12 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign9
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

1720 predictions. Top by Δscore:

VariantEffectΔscore
2:130611940:G:GTdonor_gain1.0000
2:130611940:GAG:Gdonor_gain1.0000
2:130617048:T:TAacceptor_gain1.0000
2:130617054:A:AGacceptor_gain1.0000
2:130617055:A:Gacceptor_gain1.0000
2:130617059:T:Aacceptor_gain1.0000
2:130617235:CAAGG:Cdonor_loss1.0000
2:130617236:AAGG:Adonor_loss1.0000
2:130617238:GGTA:Gdonor_loss1.0000
2:130617239:G:GAdonor_loss1.0000
2:130617240:T:Gdonor_loss1.0000
2:130620044:GC:Gacceptor_gain1.0000
2:130620044:GCAT:Gacceptor_gain1.0000
2:130620149:A:Tdonor_gain1.0000
2:130621464:A:AGacceptor_gain1.0000
2:130621465:G:GAacceptor_gain1.0000
2:130621465:GAACT:Gacceptor_gain1.0000
2:130621602:GT:Gdonor_gain1.0000
2:130621604:G:GGdonor_gain1.0000
2:130624059:CATA:Cacceptor_loss1.0000
2:130624061:TAGA:Tacceptor_loss1.0000
2:130624062:A:AGacceptor_gain1.0000
2:130624062:A:Cacceptor_loss1.0000
2:130624063:G:GGacceptor_gain1.0000
2:130624063:GA:Gacceptor_gain1.0000
2:130632483:A:AGacceptor_gain1.0000
2:130632485:TCAAG:Tacceptor_loss1.0000
2:130632487:AAG:Aacceptor_gain1.0000
2:130632488:A:Gacceptor_gain1.0000
2:130632489:G:GGacceptor_gain1.0000

AlphaMissense

6971 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:130616804:T:CL142P0.991
2:130621519:T:CL287P0.988
2:130657119:T:CF787L0.988
2:130657121:T:AF787L0.988
2:130657121:T:GF787L0.988
2:130617102:T:CL188S0.986
2:130617105:T:CL189P0.986
2:130617201:T:CL221P0.986
2:130617065:G:CA176P0.985
2:130617134:G:CD199H0.985
2:130657128:T:CF790L0.984
2:130657130:C:AF790L0.984
2:130657130:C:GF790L0.984
2:130611861:C:AA110D0.983
2:130620139:A:TD265V0.983
2:130657767:T:AW1003R0.983
2:130657767:T:CW1003R0.983
2:130616876:A:TD166V0.982
2:130611891:T:CL120P0.981
2:130617134:G:TD199Y0.981
2:130621582:C:AA308D0.981
2:130617235:C:AN232K0.980
2:130617235:C:GN232K0.980
2:130620069:G:CG242R0.980
2:130616843:T:CL155P0.978
2:130617135:A:TD199V0.978
2:130620067:T:CL241P0.978
2:130621480:T:CL274P0.978
2:130657803:T:CF1015L0.978
2:130657805:C:AF1015L0.978

dbSNP variants (sampled 300 via entrez): RS1000305412 (2:130654459 C>G), RS1000566233 (2:130658312 G>C), RS1000626227 (2:130655938 A>C), RS1000673038 (2:130637245 C>A,T), RS1000785402 (2:130636795 A>G), RS1001464202 (2:130634416 T>C), RS1001472236 (2:130656098 T>C), RS1001619467 (2:130656966 C>G,T), RS1001798341 (2:130656414 C>T), RS1001852285 (2:130639939 T>C), RS1001914249 (2:130637966 T>A), RS1002134743 (2:130610568 T>C), RS1002421987 (2:130612960 C>T), RS1003454894 (2:130613290 ATATATATACATATG>A,ATATATATACATATGTATATATACATATG), RS1003528216 (2:130644361 T>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
beauvericinaffects cotreatment, decreases expression1
bisphenol Adecreases expression1
sodium arseniteincreases expression1
enniatinsaffects cotreatment, decreases expression1
Doxorubicindecreases expression1
Oxygenincreases expression1
Tobacco Smoke Pollutionaffects expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.